Article

Patients With Juvenile Arthritis May Face Employment Issues as Adults

Disability resulting from juvenile idiopathic arthritis may adversely affect the ability of children to achieve educational success as they grow into adulthood.

Disability resulting from juvenile idiopathic arthritis (JIA) may adversely affect the ability of children to achieve educational success as they grow into adulthood. Study findings published in Arthritis & Rheumatism, an American College of Rheumatology journal, suggest that functional disability affects educational attainment, a key to successful employment in adulthood.

To investigate the dependency between employment and educational achievement in adult patients who had JIA, researchers recruited 103 patients who were treated at the musculoskeletal unit at the Freeman Hospital in the United Kingdom (median age, 24 years; median disease duration, 19 years). The patients were surveyed about educational achievement and employment status and completed the Health Assessment Questionnaire to measure functional disability.

Functional disability was significantly lower in employed patients and in those with oligoarticular JIA. Educational achievement was not influenced by JIA subtype (oligoarticular, polyarticular rheumatoid factor [RF]-positive, polyarticular RF-negative, systemic, or others). Patients who received their secondary education certificate had greater success later in life, obtaining more professional or managerial jobs. Job stability was influenced positively by educational achievement and negatively by the disability score.

Studies have shown that early, aggressive treatment with disease-modifying antirheumatic drugs, such as methotrexate, or tumor necrosis factor α inhibitors can improve long-term outcomes for patients with JIA, it was noted, but in spite of such treatment, some patients with JIA enter adulthood with joint damage, disability, and lowered quality of life. The researchers recommended further research that helps patients determine ideal career choices and takes their disease activity into account.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.